Second Quarter 2025 Results Key Financial Results Revenue: US$483.4m (up 4.3% from ...

There's been a major selloff in Albany International Corp. shares in the week since it released its second-quarter report, with the stock down 23% to US$55.88. Results overall wer ...

Key Points Earnings per share (Non-GAAP) were $0.94 in Q2 2025 beating the analyst estimate by 9.3% (non-GAAP) and the company exceeded its non-GAAP EPS outlook by $0.08. Net sales (GAAP) reached ...

Key Points Earnings per share (GAAP) in Q2 2025 exceeded expectations, rising to $1.68 versus the analyst estimate of $1.47, and increasing 265.2% year-over-year. Net interest income on a fully ...

Q2 2025 Earnings Call Transcript August 1, 2025 Fortis Inc. beats earnings expectations. Reported EPS is $0.558, expectations ...

Q2 2025 Earnings Call Transcript August 1, 2025 IRadimed Corporation reports earnings inline with expectations. Reported EPS ...

Management reaffirmed 2025 operating earnings per share guidance of $3.28 to $3.52, with a midpoint of $3.40. Ridge stated, "I'm highly confident in our ability to deliver on our financial plan, ...

The chip designer's results and guidance were not good enough to support its highly valued stock, but its attractive business ...

Apple has just reported its third-quarter results. Here are 10 key takeaways from the iPhone and Mac maker's April-June 2025 ...

Explore PPL Corporation's Q2 2025 earnings insights, ambitious $20B infrastructure plans, and strategic ventures on data center growth.

Analysts estimate that BioNTech will report an earnings per share (EPS) of $-1.31. The market awaits BioNTech's announcement, ...

Analysts anticipate Biomarin Pharmaceutical to report an earnings per share (EPS) of $0.93. The market awaits Biomarin ...